We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules and an epirubicin + ifosfamide chemotherapy treatment for six cycles, eribulin was administered at the dose of 1.1 mg/m on days 1 and 8, every 3 weeks for a total of nine cycles. A significant reduction of the lesions was achieved after four cycles of therapy, with a good profile of tolerability. © 2020 Future Medicine Ltd.
Miano, S.T., Francini, E., Petrioli, R., Francini, G. (2020). A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient. FUTURE ONCOLOGY, 16(1s), 33-38 [10.2217/fon-2019-0600].
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
Miano S. T.;Petrioli R.;Francini G.
2020-01-01
Abstract
We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules and an epirubicin + ifosfamide chemotherapy treatment for six cycles, eribulin was administered at the dose of 1.1 mg/m on days 1 and 8, every 3 weeks for a total of nine cycles. A significant reduction of the lesions was achieved after four cycles of therapy, with a good profile of tolerability. © 2020 Future Medicine Ltd.
| File | Dimensione | Formato | |
|---|---|---|---|
|
A case of eribulin-induced regression-Miano-2020.pdf
accesso aperto
Tipologia:
PDF editoriale
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
1.98 MB
Formato
Adobe PDF
|
1.98 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1095201